The Wnt/β-catenin pathway drives increased cyclin D1 levels in lymph node metastasis in papillary thyroid cancer.

[1]  D. Lim,et al.  Unique patterns of tumor growth related with the risk of lymph node metastasis in papillary thyroid carcinoma , 2010, Modern Pathology.

[2]  H. Lee,et al.  Constitutive activation of glycogen synthase kinase-3β correlates with better prognosis and cyclin-dependent kinase inhibitors in human gastric cancer , 2010, BMC gastroenterology.

[3]  Steven J. M. Jones,et al.  Diagnostic utility of galectin-3 in thyroid cancer. , 2010, The American journal of pathology.

[4]  R. Udelsman.  Treatment of persistent or recurrent papillary carcinoma of the thyroid--the good, the bad, and the unknown. , 2010, Journal of Clinical Endocrinology and Metabolism.

[5]  S. Pai,et al.  Reoperation for recurrent/persistent well-differentiated thyroid cancer. , 2010, Otolaryngologic clinics of North America.

[6]  Zuojie Luo,et al.  Assessment of biomarkers for clinical diagnosis of papillary thyroid carcinoma with distant metastasis. , 2010, The International journal of biological markers.

[7]  Sang Hyuk Lee,et al.  Expression of cell-cycle regulators (cyclin D1, cyclin E, p27kip1, p57kip2) in papillary thyroid carcinoma , 2010, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[8]  R. Lai,et al.  Biological and clinical significance of GSK-3beta in mantle cell lymphoma--an immunohistochemical study. , 2010, International journal of clinical and experimental pathology.

[9]  Stephanie L. Lee,et al.  Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. , 2009, Thyroid : official journal of the American Thyroid Association.

[10]  T. Fahey,et al.  Molecular markers in thyroid cancer diagnostics. , 2009, The Surgical clinics of North America.

[11]  B. Jiang,et al.  Increased Expression of β-Catenin, Phosphorylated Glycogen Synthase Kinase 3β, Cyclin D1, and c-myc in Laterally Spreading Colorectal Tumors , 2009, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[12]  L. Rotstein.  The role of lymphadenectomy in the management of papillary carcinoma of the thyroid , 2009, Journal of surgical oncology.

[13]  S. Hauptmann,et al.  Lymph node dissection in the lateral neck for completion in central node-positive papillary thyroid cancer. , 2009, Surgery.

[14]  H. Dralle,et al.  Surgical approaches in thyroid cancer and lymph-node metastases. , 2008, Best practice & research. Clinical endocrinology & metabolism.

[15]  Q. Liu,et al.  Relationship between Protein Expression of VEGF-C, MMP-2 and Lymph Node Metastasis in Papillary Thyroid Cancer , 2008, The Journal of international medical research.

[16]  F. Takahashi‐Yanaga,et al.  GSK-3beta regulates cyclin D1 expression: a new target for chemotherapy. , 2008, Cellular signalling.

[17]  Steven J. M. Jones,et al.  Cell Cycle Regulators Show Diagnostic and Prognostic Utility for Differentiated Thyroid Cancer , 2007, Annals of Surgical Oncology.

[18]  P. Hall,et al.  Clinically significant prognostic factors for differentiated thyroid carcinoma , 2006, Cancer.

[19]  Chenguang Wang,et al.  Minireview: Cyclin D1: normal and abnormal functions. , 2004, Endocrinology.

[20]  R. Jope,et al.  The glamour and gloom of glycogen synthase kinase-3. , 2004, Trends in biochemical sciences.

[21]  J. Diehl.  Cycling to Cancer with Cyclin D1 , 2002, Cancer biology & therapy.

[22]  A. Kimmel,et al.  GSK3, a master switch regulating cell-fate specification and tumorigenesis. , 2000, Current opinion in genetics & development.

[23]  M. Roussel,et al.  Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization. , 1998, Genes & development.

[24]  J. Shah,et al.  Impact of lymph node metastasis in differentiated carcinoma of the thyroid: A matched‐pair analysis , 1996, Head & neck.

[25]  H. Wanebo,et al.  Recurrent Thyroid Cancer Role of Surgery Versus Radioactive Iodine (I131) , 1994, Annals of Surgery.

[26]  R. Lai,et al.  Original Article Biological and clinical significance of GSK-3β in mantle cell lymphoma-an immunohistochemical study , 2010 .

[27]  J. Woodgett,et al.  Role of glycogen synthase kinase-3 in cancer: regulation by Wnts and other signaling pathways. , 2002, Advances in cancer research.

[28]  R. Hinze,et al.  Pattern of Nodal Metastasis for Primary and Reoperative Thyroid Cancer , 2002, World journal of surgery.